V. Heinemann

Surgical treatment options following chemotherapy plus cetuximab or bevacizumab in metastatic colorectal cancer-central evaluation of FIRE-3.

U. Neumann, V. Heinemann, D. Seehofer, 2018, European journal of cancer.

Impact of lipids and lipoproteins on hepatitis C virus infection and virus neutralization.

A. Mesalam, G. Leroux-Roels, J. Siveke, 2014, World journal of gastroenterology.

Neoadjuvant treatment of borderline resectable and non-resectable pancreatic cancer.

S. Boeck, M. Haas, V. Heinemann, 2013, Annals of oncology : official journal of the European Society for Medical Oncology.

Capecitabine as Second-Line Treatment for Metastatic Cholangiocarcinoma: A Report of Two Cases

V. Heinemann, J. Stemmler, A. Schalhorn, 2002, Oncology Research and Treatment.

Primary advanced unresectable pancreatic cancer.

V. Heinemann, M. Wolf, R. Wilkowski, 2008, Recent results in cancer research. Fortschritte der Krebsforschung. Progres dans les recherches sur le cancer.

Characteristics of patients with brain metastases receiving trastuzumab for HER2 overexpressing metastatic breast cancer.

V. Heinemann, S. Kahlert, M. Untch, 2006, Breast.

CA19-9: a pedictor of response in pancreatic cancer treated with gemcitabine and cisplatin.

V. Heinemann, P. Stieber, A. Schalhorn, 1999, Anticancer Research.

Gemcitabine and cisplatin in the treatment of advanced or metastatic pancreatic cancer.

V. Heinemann, K. Possinger, M. Arning, 2000, Annals of oncology : official journal of the European Society for Medical Oncology.

Neoadjuvant Treatment of Borderline Resectable and Non-resectable Pancreatic Cancer Reviews Annals of Oncology

V. Heinemann, S. Boeck, M. Haas, 2022 .